Advertisement

Posterior Pituitary Hormone, Diabetes Insipidus

Synopsis

  • Idiopathic diabetes insipidus is rarely connected to specific skin diseases. There are no specific cutaneous manifestations; only singular reports on allergic reactions caused by vasopressin preparations are available.

  • Langerhans cell histiocytosis (LCH) is associated in up to 50% of patients with diabetes insipidus. LCH is a clonal accumulation of specific cells resembling normal epidermal Langerhans cells. The skin lesions are agglomerated red or brown papules and tumours with ulceration and incrustation. Diagnosis requires pathohistological investigation, and the singular diagnostic feature is the presence of LCH cells. For treatment, chemotherapy or radiotherapy have been performed.

Keywords

Diabetes Insipidus Nephrogenic Diabetes Insipidus Central Diabetes Insipidus Plasma Vasopressin Birbeck Granule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adam A, Rakhit G, Beeton S, Mitchenere P. Extensive subcutaneous calcification following injec tions of pitressin tannate. Br J Radiol. 1984;57(682):921–2.PubMedGoogle Scholar
  2. Bobilev D, Shelef I, Lavrenkov K, Tokar M, Man S, Baumgarten A, Ariad S. Diabetes insip-idus caused by isolated intracranial metatstases in patient with breast cancer. J Neurooncol. 2005;73(1):39–42.PubMedCrossRefGoogle Scholar
  3. Donadieu J, Rolon MA, Thomas C, Brugieres L, Plantaz D, Emile J F, Frappaz D, David M, Brauner R, Genereau T, Debray D, Cabrol S, Barthez MA, Hoang-Xuan K, Polak M; French LCH Study Group. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr. 2004;144(3):344–50.PubMedCrossRefGoogle Scholar
  4. Einaudi S, Bondone C. The effects of head trauma on hypothalamic-pituitary function in children and adolescents. Curr Opin Pediatr. 2007;19(4):465–70.PubMedCrossRefGoogle Scholar
  5. Favara BE, Jaffe MB. The histopathology of Langerhans cell histiocytosis. Br J Cancer 1994;70(Suppl 23):S17–S23Google Scholar
  6. Ghirardello S, Garrè ML, Rossi A, Maghnie M. The diagnosis of children with central diabetes insipidus. J Pediatr Endocrinol Metab. 2007;20(3):359–75.PubMedGoogle Scholar
  7. Ghirardello S, Malattia C, Scagnelli P, Maghnie M. Current perspective on the pathogenesis of central diabetes insipidus. J Pediatr Endocrinol Metab. 2005;18(7):631–45.PubMedGoogle Scholar
  8. Houck WA, Olson KB, Horton J. Clinical features of tumor metastasis to the pituitary. Cancer. 1970;26(3):656–9.PubMedCrossRefGoogle Scholar
  9. Itabashi A, Katayama S, Yamaji T. Hypersensitivity to chlorobutanol in DDAVP solution. Lancet. 1982;1(8263):108.PubMedCrossRefGoogle Scholar
  10. Kajiyama H, Terai C, De Bellis A, Bizzarro A, Bellastella A, Ohta S, Okamoto H, Uesato M, Hara M, Kamatani N. Vasopressin cell antibodies and central diabetes insipidus in a patient with systemic lupus erythematosus and dermatomyositis. J Rheumatol. 2004;31(6):1218–21.PubMedGoogle Scholar
  11. Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson J P, Besser GM, Grossman AB. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab. 2000;85(4):1370–6.PubMedCrossRefGoogle Scholar
  12. Khiari K, Cherif L, Hadj Ali I, Turki S, Lakhoua Y, Ben Abdallah N, Ben Maiz H. Central diabetes insipidus with Behcet disease. A case report. Ann Endocrinol (Paris). 2003;64(6):426–7.Google Scholar
  13. Kondo Y, Morimoto T, Nishio T, Aslanova U F, Nishino M, Farajov EI, Sugawara N, Kumagai N, Ohsaga A, Maruyama Y, Takahashi S. Phylogenetic, ontogenetic, and pathological aspects of the urine-concentrating mechanism. Clin Exp Nephrol. 2006;10(3):165–74.PubMedCrossRefGoogle Scholar
  14. Lin KD, Lin JD, Hsu HH, Juang JH, Huang MJ, Huang HS. Endocrinological aspects of Langerhans cell histiocytosis complicated with diabetes insipidus. J Endocrinol Invest. 1998;21(7):428–33.PubMedGoogle Scholar
  15. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, Tinelli C, Gallucci M, Bernasconi S, Boscherini B, Severi F, Arico M. Central diabetes insipidus in children and young adults. N Engl J Med. 2000;343(14):998–1007.PubMedCrossRefGoogle Scholar
  16. Majzoub JA, Srivatsa A. Diabetes insipidus: clinical and basic aspects. Pediatr Endocrinol Rev. 2006;4 Suppl 1:60–5.PubMedGoogle Scholar
  17. Makras P, Alexandraki KI, Chrousos G P, Grossman AB, Kaltsas GA. Endocrine manifestations in Langerhans cell histiocytosis. Trends Endocrinol Metab. 2007;18(6):252–7.PubMedCrossRefGoogle Scholar
  18. Maurer J, Busch M, Matthaei D, Helwig A, Duhmke E. Diabetes insipidus und Mammakarzi-nom —Bedeutung der NMR-Tomografie (MRT) zur Therapieplanung. Strahlenther Onkol. 1993;169(2):126–8.PubMedGoogle Scholar
  19. Nanduri VR, Bareille P, Pritchard J, Stanhope R. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf). 2000;53(4):509–15.CrossRefGoogle Scholar
  20. Sands JM, Bichet DG; American College of Physicians; American Physiological Society. Nephrogenic diabetes insipidus. Ann Intern Med. 2006;144(3):186–94.PubMedGoogle Scholar
  21. Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 2006;17(7):1820–32.PubMedCrossRefGoogle Scholar
  22. Shimizu H, Obi T, Miyajima H. Anhidrosis: an unusual presentation of diabetes insipidus. Neurology 1997;49(6):1708–10.PubMedGoogle Scholar
  23. Tham LC, Millward MJ, Lind MJ, Cantwell BM. Metastatic breast cancer presenting with diabetes insipidus. Acta Oncol. 1992;31(6):679–80.PubMedCrossRefGoogle Scholar
  24. The French Langerhans' Cell Histiocytosis Study Group. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child. 1996;75(1):17–24.CrossRefGoogle Scholar
  25. Thibonnier M. Genetics of vasopressin receptors. Curr Hypertens Rep. 2004;6(1):21–6.PubMedCrossRefGoogle Scholar
  26. Tsagarakis S, Tzanela M, Dimopoulou I. Diabetes insipidus, secondary hypoadrenalism and hypothy-roidism after traumatic brain injury: clinical implications. Pituitary 2005;8(3–4):251–4.PubMedCrossRefGoogle Scholar
  27. Yap H Y, Tashima CK, Blumenschein GR, Eckles N. Diabetes insipidus and breast cancer. Arch Intern Med. 1979;139(9):1009–11.PubMedCrossRefGoogle Scholar
  28. Yokota M, Matsukura S, Kaji H, Taminato T, Fujita T. Allergic reaction to DDAVP (deamino arginin vasopressinin) in diabetes insipidus: successful treatment with its graded doses. Endo-crinol Jpn. 1982;29(4):475–7.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Personalised recommendations